about
The public road to high-quality curated biological pathwaysPeroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewChronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining miceThe pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.Targeting inflammation in diabetes: Newer therapeutic optionsPeroxisome proliferator-activated receptors in regulation of cytochromes P450: new way to overcome multidrug resistance?The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathyInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsInhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-γ and down-regulation of VEGFR-2 expressionStructural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand BindingPPARγ as a Novel Therapeutic Target in Lung CancerPPARγ in Bacterial Infections: A Friend or Foe?PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsLoss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skinThe nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity.Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet.PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studiesIncreased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse.Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.Minireview: Challenges and opportunities in development of PPAR agonistsNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy.Interleukin-17 regulation: an attractive therapeutic approach for asthmaRelationship between environmental phthalate exposure and the intelligence of school-age children.Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.Peroxisome proliferator-activated receptors (PPARs)-independent functions of fish oil on glucose and lipid metabolism in diet-induced obese mice.Low-level laser therapy restores the oxidative stress balance in acute lung injury induced by gut ischemia and reperfusion.Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responsesKnockdown of PPAR δ gene promotes the growth of colon cancer and reduces the sensitivity to bevacizumab in nude mice model.The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma
P2860
Q19862849-AF2390D3-6059-4C3E-A217-AA237A80B8D9Q21245560-48BE80ED-01CE-4A8B-B062-149E81E16BDFQ21245733-A62B2D8C-6774-43E8-B903-33507D528A14Q24561401-A794EF11-B4CC-464B-A2F1-0E2FA230A825Q24642070-C36D0274-38EC-45D0-8684-0841678721AFQ24814517-2373FAC8-8C48-4653-BA2A-61FB127653E4Q24816834-A77236D9-0C13-4480-B9EF-FA9B4706D3D1Q26852726-B96540B4-39DC-4E50-84D0-63876A126B02Q26864661-A40A44DB-862C-437E-96F9-A064A74C5DDAQ26865958-B4CAE0FF-2EF2-4E03-A1F7-CDA6F731EEB6Q26866480-DD2CAC91-5059-40E2-92FE-E5795398E241Q27332433-0CA3BB76-4E67-4341-949F-58BD480CBB01Q27679169-56CF0B84-9FA9-433E-B23C-CD4A4292D61BQ28068114-054D75C3-675F-45D9-A020-864146D558DEQ28070173-9C108A7A-FC9F-49FE-A135-8CAE84AAF9E1Q28574163-651B49D6-9EB6-4800-B2D3-906FA7184378Q28580246-3DEE93C1-6C6D-4EB9-BEEA-B2E3DCC3292EQ28588458-5A06DA6B-600B-47B7-8DD0-C4771662DE5EQ30357715-739480CE-8144-41AE-8AA8-99FD1BA9C4D3Q30370399-814288FC-026C-47E7-90C5-5C9D3BBBEFFDQ33231599-C8891547-9B23-4ED6-AF0F-240340053FCDQ33294481-48F3248C-1C48-4D4F-AADF-C9CAE0A8B560Q33372436-E193A980-2389-4B6A-96CB-99DB9B6BC68DQ33573305-A40E408F-8ACD-43D9-A4B6-91202CA0DB5BQ33596717-274A9932-A0CB-4944-912E-9CAAF6D6B4E8Q33600094-6F608A08-C29E-4315-8E1C-9ADD3944D192Q33618276-46DB73FB-4191-4FF9-9D6A-FB4D2FD32FC9Q33631921-8F6CC369-40CC-41F6-8E1D-47C3A1345628Q33664095-AC3BBC03-1898-4880-A143-C7FD834D177EQ33674615-42F195A7-9C4C-4826-9094-7626C513D9DCQ33732839-3EBCD53D-1C2D-4D22-B3D3-BCC096DD8E2CQ33951731-944C04D3-5372-4984-9880-E47610AAC762Q34063032-F8B6E5AF-1F24-4A99-A7DC-9B3E52842662Q34084838-52BD7997-ACA1-472B-B34A-061F62850C4EQ34097903-41C0DAC5-8D2A-440D-A43C-749158B30A01Q34174646-66CC2E49-940B-449F-BB44-75A7138FBB1DQ34375448-D6B5664A-47D9-4C11-97BA-D89468B7F45BQ34459867-BD5175E7-2B6E-464B-BE65-E59C1ACC612FQ34673917-0C4DE828-3F20-48FA-970E-BB6594CCB611Q35080151-60EDDEE0-0E4D-45F5-90C6-DD9F6A89A5C2
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
An overview on biological mechanisms of PPARs.
@ast
An overview on biological mechanisms of PPARs.
@en
An overview on biological mechanisms of PPARs.
@nl
type
label
An overview on biological mechanisms of PPARs.
@ast
An overview on biological mechanisms of PPARs.
@en
An overview on biological mechanisms of PPARs.
@nl
prefLabel
An overview on biological mechanisms of PPARs.
@ast
An overview on biological mechanisms of PPARs.
@en
An overview on biological mechanisms of PPARs.
@nl
P1476
An overview on biological mechanisms of PPARs
@en
P2093
Bhavani Prasad Kota
Tom Hsun-Wei Huang
P356
10.1016/J.PHRS.2004.07.012
P577
2005-02-01T00:00:00Z